Phase II angiogenesis stimulators

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.9, 2013-09, pp. : 1157-1166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Annexin II in Angiogenesis and Tumor Progression: A Potential Therapeutic Target

Current Pharmaceutical Design, Vol. 13, Iss. 35, 2007-12 ,pp. : 3568-3575

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Phase I and Phase II Drug Metabolism

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 204-219

Bentham Science Publishers

Access to resources Recommend Favorite

Dalcetrapib: a review of Phase II data

By Robinson Jennifer G

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 6, 2010-06 ,pp. : 795-805

Informa Healthcare

Access to resources Recommend Favorite

Randomized Phase II Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 802-816

Taylor & Francis Ltd

Access to resources Recommend Favorite

Imidazolines as efficacious glucose-dependent stimulators of insulin secretion

By Jakobsen P. Madsen P. Andersen H.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 357-362

Elsevier

Access to resources Recommend Favorite